SMARCB1 and angioimmunoblastic T-cell lymphoma: Nevertheless, very low SMARCB1 expression levels were significantly more frequent in the PTCL-NOS than in the AITL group (Fig. 1B; adjusted p < 0.0001, Wilcoxon test).